articleThe LancetAug 30, 2008Closed access

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,103
total citations
FWCI
90.32
Percentile
100%
References
33
Citations per year

Authors

1

Topics & keywords

Keywords
  • Rosuvastatin
  • Medicine
  • Placebo
  • Heart failure
  • Internal medicine
  • Randomized controlled trial
  • Cardiology
  • Double blind
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding